Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Bristol-Myers Squibb.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00254293
First received: November 15, 2005
Last updated: April 30, 2012
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2012 |
| Primary Completion Date: | May 2007 (Final data collection date for primary outcome measure) |
No publications provided by Bristol-Myers Squibb
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):